Innovative Research of America(IRA) 是一家致力研发于药物定量定时缓释系统的专业化公司，又称Matrix-Driven Delivery (MDD) 给药系统。该给药系统由一个可生物吸收的基质组成，含有定量可控的活性给药成分，可以以设定的剂量在一定时间范围内进行给药。

Since it is not easy to administer drugs and hormones orally to research animals, several delivery methods have been devised as alternatives.  However, most scientists continue to labor with unreliable injectables to conduct their research.

Matrix-Driven Delivery (MDD) Pellet（MDD片剂）的优势

Saves time

Ready-to-implant

Insures controlled product release over time

Avoids "peak and valley" effects

Guarantees consistent product preparation

Extends product life against spontaneous breakdown

Extends product life against host-related breakdown

Minimizes experimental variables

Insures safety of the experimenter

Reduces neurophysiological trauma to animal/no excessive handling

Generates more meaningful and reproducible results

Superior to conventional delivery methods

Enhances experimental efficiency

Frees valuable time for creative research

Saves money

Innovative Research of America的主要产品包括：

ANTIBIOTICS

ANTI-INFLAMMATORY AGENTS

ANTI-NEOPLASTICS

CATECHOLAMINES & RELATED PRODUCTS

CORTICOIDS & DIURETICS

ESTROGENS & ANTI-ESTROGENS

FATTY ACIDS

MISCELLANEOUS PRODUCTS

NUCLEOTIDE RELATED PRODUCTS

PLACEBO

PROGESTINS

PROSTAGLANDINS

THYROIDS

VITAMINS

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Nu-Tek Biosciences品牌。

Nu-Tek BioSciences 为生物技术和制药公司开发和生产蛋白胨及蛋白质水解物。Nu-Tek BioSciences产品组合广泛应用于多种领域，从哺乳动物细胞培养到工业发酵，这些产品还用于制造无过敏原的益生菌和其他高价值的营养产品。Nu-Tek BioSciences 正在为蛋白胨、水解物和酵母提取物的制造设定更高标准。作为行业领先的解决方案制造商，Nu-Tek 提供卓越的客户服务和性能优化的细胞营养解决方案。公司利用其符合 ISO 和 GMP 标准的设施，采用专有工艺进行生产，几乎可以生产任何所需的蛋白胨或水解物，这使得 Nu-Tek 成为定制制造的首选。经过行业领先的制药和生物技术公司的审核和认可，Nu-Tek持续改进产品质量。

艾美捷科技代理ATTO Biotech全系列产品。

ATTO Biotech专注于开发和提供生命科学研发用的创新产品及服务。公司位于中国上海，主要为全球生物医药类企业及研发机构提供高度专业化的细胞培养材料和技术服务。爱拓生物科技推出的含组织特异性基质成分细胞培养添加剂，突破了传统细胞培养技术的瓶颈，为全球医药和医学生物学研究者提供了简单、精确和高效的解决方案，是划时代技术革命性产品。

ATTO BIOTECH is a German company based inShanghaiChina. We are no giant on an international scale but a global leader in producing cell culture supplements containing tissue-specific decellularized extracellular matrix (ECM) components. Customers choose ATTO BIOTECH for its true research tools of tomorrow to create clinically relevant in vitro solutions that fundamentally change the way we understand human diseases. Our range of highly innovative products has wide applications in life sciences industries and academic institutions.

主要产品包括：

心脏组织特异性细胞外基质添加剂

(Cat# ECM201) heart-specific ECM supplements (hECMs), 10×

动/静脉血管组织特异性细胞外基质添加剂

(Cat# ECM202) artery/vein-specific ECM supplements (aECMs/vECMs), 10×

脑组织特异性细胞外基质添加剂

(Cat# ECM203) brain-specific ECM supplements (bECMs), 10×

胃肠组织特异性细胞外基质添加剂

(Cat# ECM204) gastrointestine-specific ECM supplements (gECMs), 10×

食管组织特异性细胞外基质添加剂

(Cat# ECM205) esophagus-specific ECM supplements (eECMs), 10×

肾胀组织特异性细胞外基质添加剂

(Cat# ECM206) kidney-specific ECM supplements (kECMs), 10×

肝组织特异性细胞外基质添加剂

(Cat# ECM207) liver-specific ECM supplements (liECMs), 10×

脾组织特异性细胞外基质添加剂

(Cat# ECM208) spleen-specific ECM supplements (sECMs), 10×

肺组织特异性细胞外基质添加剂

(Cat# ECM209) lung-specific ECM supplements (luECMs), 10×

气管组织特异性细胞外基质添加剂

(Cat# ECM210) trachea-specific ECM supplements (tECMs), 10×